Skip to main content

Table 2 TTFields-related adverse events

From: Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China

 

CA-TTF (N = 41)

A-TTF (N = 31)

Skin AEs, n (%)

Dermatitisa

 Grade 1 AEs, n (%)

9 (21.95%)

8 (25.81%)

 Grade 2 AEs, n (%)

14 (34.15%)

9 (32.26%)

 Grade 3 AEs, n (%)

1 (2.44%)

1 (3.23%)

Pruritus

 Grade 1 AEs, n (%)

4 (9.76%)

3 (9.68%)

 Grade 2 AEs, n (%)

2 (4.88%)

1 (3.22%)

Electric sensation

 Grade 1 AEs, n (%)

1 (2.44%)

 

Skin burning sensation

 Grade 1 AEs, n (%)

1 (2.44%)

1 (3.22%)

  1. aDermatitis included scalp irritation, dry skin, folliculitis, erythema, color change, or rash
Back to article page

Chinese Neurosurgical Journal

ISSN: 2057-4967

Contact us